• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保乳手术后放疗的时变效应(DCIS)。

The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.

机构信息

Department of Radiation Oncology, Toronto, ON, Canada.

ICES, Toronto, ON, Canada.

出版信息

Breast Cancer Res Treat. 2019 Nov;178(1):221-230. doi: 10.1007/s10549-019-05377-8. Epub 2019 Jul 31.

DOI:10.1007/s10549-019-05377-8
PMID:31368035
Abstract

BACKGROUND

A better understanding underlying radiation (RT) response after breast-conserving surgery (BCS) is needed to mitigate over-treatment of DCIS. The hazard ratio (HR) measures the effect of RT but assumes the effect is constant over time. We examined the hazard function adjusted for adherence to surveillance mammography to examine variations in LR risk and the effect of RT over time.

METHODS

Crude hazard estimates for the development of LR in a population cohort of DCIS treated by BCS ± RT were computed. Multivariable extended Cox models and hazard plots were used to examine the association between receipt of RT and risk of each outcome adjusted for baseline covariates and adherence to mammography.

RESULTS

Population cohort includes 3262 women treated by BCS; 1635 received RT. Median follow-up was 13 years. LR developed in 364 women treated by BCS alone and 274 treated with RT. LR risk peaked at 2 years, declined until year 7, and then remained steady. The peak hazard of LR was associated with adverse features of DCIS. Early LR risk was attenuated in patients treated with RT but late annual risks of LR and invasive LR were similar among the two treatment groups. On multivariate analysis, RT was associated with a reduction in early LR risk (HR = 0.52, 95% CI 0.43-0.63, p < 0.0001) but did not reduce the risk of late LR (HR = 0.89, 95% CI: 0.67, 1.19, p = 0.44) (interaction, p = 0.002).

CONCLUSIONS

The effect of RT is not uniform over time and greatest in the first 7 years after BCS for DCIS, which can guide future research to understand mechanisms underlying RT response and optimize future management of DCIS.

摘要

背景

为了减轻对 DCIS 过度治疗的程度,需要更好地了解保乳手术后(BCS)的放射治疗(RT)反应。风险比(HR)衡量 RT 的效果,但假设效果随时间保持不变。我们检查了调整了监测乳房 X 光检查依从性的危害函数,以检查 LR 风险的变化以及 RT 随时间的影响。

方法

计算了接受 BCS ± RT 治疗的 DCIS 人群队列中发生 LR 的粗危害估计值。多变量扩展 Cox 模型和危害图用于检查接受 RT 与每种结局的风险之间的关联,调整了基线协变量和乳房 X 光检查的依从性。

结果

人群队列包括 3262 名接受 BCS 治疗的女性;其中 1635 人接受了 RT。中位随访时间为 13 年。单独接受 BCS 治疗的 364 名妇女和接受 RT 治疗的 274 名妇女发生了 LR。LR 风险在 2 年内达到峰值,直到第 7 年下降,然后保持稳定。LR 的高峰风险与 DCIS 的不良特征有关。接受 RT 治疗的患者早期 LR 风险降低,但两组晚期 LR 和浸润性 LR 的年风险相似。多变量分析显示,RT 与早期 LR 风险降低相关(HR=0.52,95%CI 0.43-0.63,p<0.0001),但不能降低晚期 LR 风险(HR=0.89,95%CI:0.67,1.19,p=0.44)(交互作用,p=0.002)。

结论

RT 的效果并非随时间均匀,在 BCS 后 7 年内对 DCIS 的效果最大,这可以指导未来的研究,以了解 RT 反应的机制并优化 DCIS 的未来管理。

相似文献

1
The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.保乳手术后放疗的时变效应(DCIS)。
Breast Cancer Res Treat. 2019 Nov;178(1):221-230. doi: 10.1007/s10549-019-05377-8. Epub 2019 Jul 31.
2
Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.多灶微浸润与保乳手术后导管原位癌女性浸润性局部复发风险增加相关。
Breast Cancer Res Treat. 2019 Nov;178(1):169-176. doi: 10.1007/s10549-019-05364-z. Epub 2019 Jul 19.
3
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.保乳术后省略放疗治疗单纯 DCIS 并不能降低挽救性乳房切除术的风险。
Breast. 2018 Feb;37:181-186. doi: 10.1016/j.breast.2017.07.002. Epub 2017 Aug 3.
4
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.多基因表达分析与保乳术后放射治疗对导管原位癌的获益。
J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw256.
5
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.导管原位癌保乳治疗加或不加放疗:欧洲癌症研究与治疗组织III期随机试验10853的十年结果——欧洲癌症研究与治疗组织乳腺癌协作组和欧洲癌症研究与治疗组织放疗组的一项研究
J Clin Oncol. 2006 Jul 20;24(21):3381-7. doi: 10.1200/JCO.2006.06.1366. Epub 2006 Jun 26.
6
Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy.保乳治疗下大乳腺导管原位癌(DCIS)病变女性的长期结局。
Breast Cancer Res Treat. 2022 Feb;192(1):223-233. doi: 10.1007/s10549-021-06488-x. Epub 2022 Jan 27.
7
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.一项基于人群的验证性研究,评估DCIS评分对仅接受保乳手术治疗的个体复发风险的预测作用。
Breast Cancer Res Treat. 2015 Jul;152(2):389-98. doi: 10.1007/s10549-015-3464-6. Epub 2015 Jun 29.
8
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.激素状态对保乳手术加放疗治疗导管原位癌结局的影响:来自两个大型机构系列的长期经验
Breast. 2017 Jun;33:139-144. doi: 10.1016/j.breast.2017.03.017. Epub 2017 Apr 4.
9
Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.广泛纯导管原位癌≥4cm 行保乳治疗与乳房切除术的局部复发比较
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):381-388. doi: 10.1016/j.ijrobp.2018.09.022. Epub 2018 Sep 22.
10
Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.基于人群的佛蒙特 DCIS 队列中,DCIS 诊断后第二事件的时变风险。
Breast Cancer Res Treat. 2019 Feb;174(1):227-235. doi: 10.1007/s10549-018-5048-8. Epub 2018 Nov 17.

引用本文的文献

1
An early economic evaluation of active surveillance for low-risk ductal carcinoma .低风险导管癌主动监测的早期经济学评估
Future Oncol. 2024 Dec;20(40):3451-3462. doi: 10.1080/14796694.2024.2421152. Epub 2024 Dec 16.
2
Time-varying effect in older patients with early-stage breast cancer: a model considering the competing risks based on a time scale.老年早期乳腺癌患者的时变效应:基于时间尺度考虑竞争风险的模型
Front Oncol. 2024 Jul 2;14:1352111. doi: 10.3389/fonc.2024.1352111. eCollection 2024.
3
Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ.
肿瘤床加量放疗对导管原位癌的局部区域控制益处
Adv Radiat Oncol. 2023 Apr 24;8(5):101254. doi: 10.1016/j.adro.2023.101254. eCollection 2023 Sep-Oct.
4
Development and application of a dynamic prediction model for esophageal cancer.食管癌动态预测模型的开发与应用
Ann Transl Med. 2021 Oct;9(20):1546. doi: 10.21037/atm-21-4964.